Sanofi CEO Paul Hudson reports a decline in U.S. vaccine demand due to misinformation and policy changes from the Trump ...

Sanofi Chief Executive Paul Hudson said on Wednesday the company is likely to see some weakness in U.S. vaccine demand this ...

A change of tone from the US authorities has introduced new uncertainties. Under health secretary and outspoken vaccine ...

New Jersey is breaking away from the federal Centers for Disease Control and Prevention's pared-down vaccine recommendations ...

Boxes of the Pfizer-BioNTech Covid-19 vaccine and Seqirus Fluad adjuvanted flu shot are kept in cold storage during an ...

Anthony Fauci privately acknowledged “impressive data” showed stronger immunity from a COVID-19 infection than vaccination ...

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...

Pfizer is a Buy at low valuation but faces a 2030 patent cliff, COVID sales declines, and LOE risks. Click here to read an ...

An analysis of safety data suggests that Abrysvo, the Pfizer respiratory syncytial virus (RSV) RSVpreF vaccine, does not ...

As we head into 2026, healthcare stands out as one of the most dislocated areas of the market. One of our favorite ideas ...

A pharmacist administers the Pfizer-BioNTech Covid-19 vaccine to an attendee of an immunization event at the L.A. Care and ...

Patent infringement lawsuits claim Pfizer, BioNTech and Moderna copied technology originally developed by Monsanto.